211 related articles for article (PubMed ID: 37754394)
1. Imiquimod-Loaded Chitosan-Decorated Di-Block and Tri-Block Polymeric Nanoparticles Loaded In Situ Gel for the Management of Cervical Cancer.
Almomen A; Badran M; Alhowyan AA; Alkholief M; Alshamsan A
Gels; 2023 Sep; 9(9):. PubMed ID: 37754394
[TBL] [Abstract][Full Text] [Related]
2. Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies.
Sanna V; Roggio AM; Posadino AM; Cossu A; Marceddu S; Mariani A; Alzari V; Uzzau S; Pintus G; Sechi M
Nanoscale Res Lett; 2011 Mar; 6(1):260. PubMed ID: 21711774
[TBL] [Abstract][Full Text] [Related]
3. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
5. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
6. Optimization of Bromocriptine-Mesylate-Loaded Polycaprolactone Nanoparticles Coated with Chitosan for Nose-to-Brain Delivery: In Vitro and In Vivo Studies.
Badran MM; Alanazi AE; Ibrahim MA; Alshora DH; Taha E; H Alomrani A
Polymers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835942
[TBL] [Abstract][Full Text] [Related]
7. Di-Block PLCL and Tri-Block PLCLG Matrix Polymeric Nanoparticles Enhanced the Anticancer Activity of Loaded 5-Fluorouracil.
Ashour AE; Badran MM; Kumar A; Rishi AK; Yassin AE
IEEE Trans Nanobioscience; 2016 Oct; 15(7):739-747. PubMed ID: 28029617
[TBL] [Abstract][Full Text] [Related]
8. Development of novel cationic chitosan-and anionic alginate-coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol.
Sanna V; Roggio AM; Siliani S; Piccinini M; Marceddu S; Mariani A; Sechi M
Int J Nanomedicine; 2012; 7():5501-16. PubMed ID: 23093904
[TBL] [Abstract][Full Text] [Related]
9. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
Shahab MS; Rizwanullah M; Alshehri S; Imam SS
Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
[TBL] [Abstract][Full Text] [Related]
10. Chitosan functionalized PCL nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy.
Dhuri A; Sriram A; Aalhate M; Mahajan S; Parida KK; Singh H; Gupta U; Maji I; Guru SK; Singh PK
Pharm Dev Technol; 2023 Jun; 28(5):460-478. PubMed ID: 37092801
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium.
Arafa MG; Girgis GNS; El-Dahan MS
Int J Nanomedicine; 2020; 15():1335-1347. PubMed ID: 32184589
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Anti-Proliferative Effect of Carboplatin in Ovarian Cancer Cells Exploiting Chitosan-Poly (Lactic Glycolic Acid) Nanoparticles.
Alassaif FR; Alassaif ER; Kaushik AK; Dhanapal J
Recent Pat Nanotechnol; 2023; 17(1):74-82. PubMed ID: 35021983
[TBL] [Abstract][Full Text] [Related]
13. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
14. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
15. Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics.
Ünal S; Doğan O; Aktaş Y
Beilstein J Nanotechnol; 2022; 13():1393-1407. PubMed ID: 36483636
[TBL] [Abstract][Full Text] [Related]
16. Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma.
Lee SY; Koo JS; Yang M; Cho HJ
J Colloid Interface Sci; 2019 May; 544():266-275. PubMed ID: 30852352
[TBL] [Abstract][Full Text] [Related]
17. Optimization and Appraisal of Chitosan-Grafted PLGA Nanoparticles for Boosting Pharmacokinetic and Pharmacodynamic Effect of Duloxetine HCl Using Box-Benkhen Design.
Salem HF; Ali AA; Rabea YK; Abo El-Ela FI; Khallaf RA
J Pharm Sci; 2023 Feb; 112(2):544-561. PubMed ID: 36063878
[TBL] [Abstract][Full Text] [Related]
18. Coating of chitosan on poly D,L-lactic-co-glycolic acid thymoquinone nanoparticles enhances the anti-tumor activity in triple-negative breast cancer.
Gao J; Kumari A; Zeng XA; Chan S; Farooq MA; Alee M; Khan SH; Rahaman A; He S; Xin X; Mehmood T
Front Chem; 2023; 11():1044953. PubMed ID: 36846852
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles.
Cirpanli Y; Yerlikaya F; Ozturk K; Erdogar N; Launay M; Gegu C; Leturgez T; Bilensoy E; Calis S; Capan Y
Pharmazie; 2010 Dec; 65(12):867-70. PubMed ID: 21284254
[TBL] [Abstract][Full Text] [Related]
20. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
[Next] [New Search]